Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 354.8B, Merck(MRK) trades at $144.04. The stock has a price-to-earnings ratio of 116.15 and currently yields dividends of 2.34%.
On 2026-10-02, Merck(MRK) stock traded between a low of $143.26 and a high of $145.39. Shares are currently priced at $144.04, which is +0.5% above the low and -0.9% below the high.
Merck(MRK) shares are trading with a volume of 7.86M, against a daily average of 11.26M.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
MRK News
Investing JNJ or MRK: One Dividend Is Built to Last, One Faces a Reckoning Both JNJ and MRK have surged in 2026, but a looming patent cliff and a balance sheet...
Merck & Company, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Asad Haider from Goldman Sachs maintained a Buy rating...
...
Analyst ratings
68%
of 31 ratingsMore MRK News
Jones analyst Debanjana Chatterjee raised the firm’s price target on Spyre Therapeutics (SYRE) to $130 from $121 and keeps a Buy rating on the shares. The firm...
shares have climbed sharply in recent years, so the live question is whether the current price is still in line with the cash the business is expected to genera...
In the latest close session, Merck (MRK Quick QuoteMRK - Free Report) was down 2.66% at $145.31. The stock fell short of the S&P 500, which registered a l...
Merck & Co Inc. (NYSE:MRK) on Wednesday presented initial results from its Phase 2b MK-7240-012 trial at the European Academy of Dermatology and Venereology (EA...
After Merck (MRK) presented Phase 2b data for tulisokibart in moderate-to-severe hidradenitis suppurativa at the EADV Congress and reported that it met the prim...
Merck (MRK) on Wednesday announced that it succeeded in a mid-stage trial for tulisokibart, its experimental therapy for an inflammatory skin condition known as...
Merck (MRK) announced the first presentation of results from MK-7240-012, a Phase 2b multicenter, randomized, double-blind, placebo-controlled trial evaluating...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.